Company Analysis
Sign in

Ocugen, Inc. (OCGN)

Nasdaq: OCGN · Biological Products, (No Diagnostic Substances) · Malvern, PA · filing with the SEC since 2006
Full chart Alerts Compare
Grade4.4
◀ Past 4.4● Present 4.3▶ Future 4.4
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 4, 2026Mar 5, 2025Apr 16, 2024Feb 28, 2023Feb 28, 2022Mar 19, 2021Mar 27, 2020Mar 22, 2019Mar 15, 2018Mar 16, 2017
Revenue4,413,0004,055,0006,036,0002,488,000043,000r0000
For lenders
Provision for credit losses···0761,00000···
Research and development39,750,00032,126,00039,573,00056,159,000r35,108,0006,354,000r8,085,52210,321,397r15,566,00021,577,000
General and administrative27,579,00026,686,00031,994,00035,400,000r22,920,0007,974,000r6,077,000r5,819,111r9,384,0008,530,000
Total operating expenses67,329,00058,812,00071,567,00091,559,000r58,028,00021,328,000r14,163,000r16,140,508r24,950,00030,307,000
Operating income-62,916,000-54,757,000-65,531,000-89,071,000r-58,028,000-21,285,000r-14,163,000r-16,140,508r-24,950,000-30,307,000
Interest expense5,188,000688,000··79,000721,000r1,768,000r3,750,630·60,000
Interest and investment income922,0001,251,000···1,0651,21419,213··
Interest income (expense), net·1,300,0002,500,0001,400,000···163,000134,000-60,000
Other income (expense), net-664,000140,000··-310,000184,000r-784,000r-12,428r-116,000-248,000
Total non-operating income (expense)-4,930,000703,0002,453,0002,267,000r-389,000-537,000r-6,080,000r-2,079,156r-1,464,00014,099,000
Income before income taxes-67,846,000-54,054,000-63,078,000-86,804,000r-58,417,000-21,822,000-20,243,000-8,643,000-26,415,000-16,207,000r
Income tax expense0000-52,00000···
Net income including non-controlling interests···-81,351,000-58,365,000-21,822,000r-20,243,000r-18,219,664r-26,414,000·
Net income-67,846,000-54,054,000-63,078,000-86,804,000r-58,365,000-21,822,000r-20,243,000r-18,219,664r-26,414,000-16,208,000
Net income to common shareholders··-63,078,000-86,804,000-58,365,000-34,368,000r-20,243,000r-18,219,664r-22,499,000-13,863,000
Earnings per share, basic··-0.26-0.40r-0.30-0.31-1.46-0.23-0.99-0.97
Earnings per share, diluted··-0.26-0.40r-0.30-0.31-1.46-0.79-0.99-2.18
Earnings per share, basic and diluted·····-0.31-1.46-3.67··
Weighted average shares, basic··244,327,057214,600,051195,013,043112,236,11013,893,81936,398,45022,669,81914,256,954
Weighted average shares, diluted··244,327,057214,600,051195,013,043112,236,11013,893,81937,090,19722,669,81914,389,192
Weighted average shares, basic and diluted·····112,236,11013,893,8194,960,552··
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
us-gaap:SalesRevenueNet
Provision for credit losses set aside for loans that may not be repaidus-gaap:ProvisionForLoanLossesExpensed
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton OCGN · research, not advice